Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Microsoft
MSFT
|
$3.26B |
| 2 |
CSX Corp
CSX
|
$1.33B |
| 3 |
Micron Technology
MU
|
$944M |
| 4 |
Verizon
VZ
|
$896M |
| 5 |
Harley-Davidson
HOG
|
$776M |
Top Sells
| 1 |
Union Pacific
UNP
|
$1.51B |
| 2 |
Philip Morris
PM
|
$1.38B |
| 3 |
American International
AIG
|
$1.25B |
| 4 |
McKesson
MCK
|
$1.21B |
| 5 |
Caterpillar
CAT
|
$985M |
Sector Composition
| 1 | Healthcare | 17.27% |
| 2 | Technology | 16.26% |
| 3 | Consumer Discretionary | 11.9% |
| 4 | Financials | 11.32% |
| 5 | Communication Services | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Booking.com
BKNG
$181B
| $3.04B | 0.95% | 1,622,668 +108,187 | +7% | +$202M |
|
27
Thermo Fisher Scientific
TMO
$186B
| $3.02B | 0.95% | 17,304,897 +3,973,136 | +30% | +$693M |
|
28
JPMorgan Chase
JPM
$829B
| $2.9B | 0.91% | 31,714,763 +765,082 | +2% | +$69.9M |
|
29
Canadian Natural Resources
CNQ
$65.9B
| $2.82B | 0.88% | 97,642,140 -2,963,591 | -3% | -$85.5M |
|
30
Medtronic
MDT
$119B
| $2.79B | 0.87% | 31,458,396 -2,187,417 | -7% | -$194M |
|
31
Exxon Mobil
XOM
$487B
| $2.55B | 0.8% | 31,570,269 +2,058,060 | +7% | +$166M |
|
32
Teva Pharmaceuticals
TEVA
$21.1B
| $2.54B | 0.79% | 76,325,059 +9,260,426 | +14% | +$308M |
|
33
Wells Fargo
WFC
$263B
| $2.51B | 0.79% | 45,327,803 +7,445,414 | +20% | +$413M |
|
34
GE Aerospace
GE
$292B
| $2.46B | 0.77% | 91,205,460 +14,316,281 | +19% | +$387M |
|
35
Boeing
BA
$177B
| $2.46B | 0.77% | 12,439,703 -3,703,138 | -23% | -$732M |
|
|
TFCFA
36
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $2.43B | 0.76% | 85,581,646 +14,398,422 | +20% | +$408M |
|
37
Lockheed Martin
LMT
$106B
| $2.38B | 0.75% | 8,582,761 -398,800 | -4% | -$111M |
|
38
Abbott
ABT
$231B
| $2.31B | 0.72% | 47,589,663 +14,918,038 | +46% | +$725M |
|
39
Illumina
ILMN
$15.8B
| $2.26B | 0.71% | 13,011,697 -944,283 | -7% | -$164M |
|
40
Las Vegas Sands
LVS
$39.6B
| $2.23B | 0.7% | 34,911,446 -2,681,809 | -7% | -$171M |
|
41
Skyworks Solutions
SWKS
$11.1B
| $2.21B | 0.69% | 23,040,672 +12,650 | +0.1% | +$1.21M |
|
42
Coca-Cola
KO
$297B
| $2.17B | 0.68% | 48,442,413 -2,981,078 | -6% | -$134M |
|
43
Dominion Energy
D
$51.1B
| $2.1B | 0.66% | 27,375,077 -2,475,551 | -8% | -$190M |
|
|
RAI
44
DELISTED
Reynolds American Inc
RAI
| $1.97B | 0.62% | 30,352,214 -1,186,053 | -4% | -$77.1M |
|
45
McDonald's
MCD
$224B
| $1.85B | 0.58% | 12,058,661 +1,572,074 | +15% | +$241M |
|
46
AT&T
T
$209B
| $1.84B | 0.58% | 48,874,024 -5,478,401 | -10% | -$207M |
|
47
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.81B | 0.57% | 10,662,527 +501,685 | +5% | +$85M |
|
48
Halliburton
HAL
$19.4B
| $1.77B | 0.55% | 41,348,303 -13,451,258 | -25% | -$575M |
|
49
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.72B | 0.54% | 18,898,699 -744,734 | -4% | -$67.6M |
|
50
Kellanova
K
$27.6B
| $1.67B | 0.52% | 24,031,728 +8,495,714 | +55% | +$590M |
|